Wealthgate Family Office’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Wealthgate Family Office's MRK Position: Q2 2021 in Review
Wealthgate Family Office sold out of Merck (MRK) in Q2 2021, closing a stake of 7,267 shares — an estimated $535K sold.
Wealthgate Family Office first reported a position in MRK in Q4 2020 and held it in 2 quarters. The position peaked at $567K in Q4 2020. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.
- Wealthgate Family Office reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
- Wealthgate Family Office sold 7,267 Merck shares in Q2 2021, an estimated $535K.
- Wealthgate Family Office first reported a position in Merck in Q4 2020 and held it in 2 quarters.
- Wealthgate Family Office's Merck position peaked at $567K in Q4 2020.
- 2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.
Based on Wealthgate Family Office's 13F filing for Q2 2021, filed 11 Aug 2021.